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Abstract  
Despite more than a decade of empirical work on the role 
of genetic polymorphisms in the serotonin system on be-
havior, the details across levels of analysis are not well un-
derstood. We describe a mathematical model of the genetic 
control of presynaptic serotonergic function that is based 
on control theory, implemented using systems of differen-
tial equations, and focused on better characterizing path-
ways from genes to behavior. We present the results of 
model validation tests that include the comparison of sim-
ulation outcomes with empirical data on genetic effects on 
brain response to affective stimuli and on impulsivity. Pat-
terns of simulated neural firing were consistent with recent 
findings of additive effects of serotonin transporter and 
tryptophan hydroxylase-2 polymorphisms on brain activa-
tion. In addition, simulated levels of cerebral spinal fluid 
5-hydroxyindoleacetic acid (CSF 5-HIAA) were negatively 
correlated with Barratt Impulsiveness Scale (Version 11) 
Total scores in college students (r = −.22, p = .002, N = 187), 
which is consistent with the well-established negative cor-
relation between CSF 5-HIAA and impulsivity. The results 
of the validation tests suggest that the model captures im-
portant aspects of the genetic control of presynaptic sero-
tonergic function and behavior via brain activation. The 
proposed model can be: (1) extended to include other sys-
tem components, neurotransmitter systems, behaviors and 
environmental influences; (2) used to generate testable 
hypotheses. 
Keywords: cybernetic, control system, simulation, genetic 
polymorphism 
Introduction
Characterizing pathways from genes to behavior will 
be the primary task for generations of behavior geneti-
cists. The Nature versus Nurture controversy that dom-
inated the first two or three decades of behavior genet-
ics no longer inflames passion. That genetic variation in 
a population is associated with individual differences 
in behavior in that population, for virtually all behav-
iors that psychologists find worthy of study, is no lon-
ger controversial (Gottesman and Hanson 2005; Mc-
Clearn 2004). The task of characterizing the mechanisms 
by which genetic polymorphisms produce individual 
differences in behavior makes up the bulk of the fasci-
nating, yet difficult, work that lies ahead for twenty-first 
century behavior geneticists (Green et al. 2008; Plomin et 
al. 2003). Such work cannot be easily done in isolation; 
it will require cross-disciplinary training and collabora-
tion across disciplines. Because the effects of genes on 
phenotypes are likely to be dependent on both the en-
vironmental and genetic context, it is important to con-
sider the dynamics of such interaction and co-action 
to understand pathways from genes to behavior (Mc-
Clearn 2004). 
As all roads once led to Rome, all pathways from 
genes to behavior lead to the brain. While there may be 
minor exceptions to this rule, as in the case of reflexes, 
for the vast majority of behaviors of interest to behav-
ior geneticists the brain is the most important point of 
interest on the route. Such a statement may seem to be 
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a platitude, but it is intended to orient behavior genetic 
analyses towards systematically elucidating relevant 
components and pathways in a systems approach. For 
those investigators interested in constructs such as self-
regulation and emotion, and in disorders that arise by 
dysfunctional behavioral or emotional control the sero-
tonin neurotransmitter system is a good candidate for a 
systems behavior genetic approach (Carver et al. 2008). 
Serotonin system is a good candidate
Serotonin has been studied as a neurotransmitter for 
over 50 years, which has produced a sizeable corpus of 
data. A recent PubMed search of “serotonin” produced 
over 107,800 hits. Serotonin-containing neurons have 
been studied in the nervous systems of several species 
across taxa including aplysia (Glanzman 2008), lobsters 
(Kravitz 2000), fruit flies (Vomel and Wegener 2008), 
dogs (Vage and Lingaas 2008), mice (Murphy and Lesch 
2008), monkeys (Barr et al. 2003a, b), and humans (Canli 
and Lesch 2007; Gotlib et al. 2008; Haghighi et al. 2008; 
Rao et al. 2007; Williams et al. 2003). The power of con-
vergent evidence can be brought to bear when studying 
associations between individual differences in the struc-
ture or function of the serotonin system and behavior 
across taxonomic units. 
The projection systems of serotonergic neurons in 
the mammalian central nervous system are identified 
(Baumgarten and Grozdanovic 1999). Most serotonergic 
neurons have cell bodies in the raphe nuclei and proj-
ect to many brain areas including the prefrontal cortex 
and the amygdala. The components of the serotoner-
gic system are described and include at least 14 recep-
tor subtypes (Hartig 1999), metabolic enzymes (Hota-
misligil and Breakefield 1991; Veenstra-VanderWeele 
and Cook 2003), and a reuptake transporter (Lesch et al. 
1993), among others. Genetic polymorphisms have been 
identified in each of the components that influence sero-
tonergic function either in the structural genes, the regu-
latory regions or the introns. 
Serotonin modulates a wide array of behaviors and 
behavioral states including, but not limited to, mood, 
arousal, impulsivity, feeding, motor behavior and ag-
gression (Lucki 1998). Several behavioral disorders 
such as depression (Johnson 2004; Leonardo and Hen 
2006; Levinson 2006), alcohol use disorders (Feinn et 
al. 2005; Johnson 2004) and obsessive compulsive dis-
order (Baumgarten and Grozdanovic 1998; El Mansari 
and Blier 2006) are linked to serotonergic dysfunction. 
Some of the effects of serotonergic dysfunction are man-
ifest through altered brain development, which can be 
permanent and influence risk for subsequent develop-
ment of behavioral disorders (Thompson and Stanwood 
2008). Such developmental effects may be the result of 
exposure to early life stress and affect risk for adult on-
set disorders in a genotype dependent manner (Caspi et 
al. 2002, 2003); but also see (Risch et al. 2009). 
Measures of serotonin function can be defined as 
traits with complex genetic architecture, in that they do 
not appear to be inherited in a simple, Mendelian fash-
ion, and that complicating factors such as epistasis (Pe-
zawas et al. 2008; Stoltenberg 2005), epigenesis (Philib-
ert et al. 2007, 2008a, 2008b), gender moderation and 
ethnic differences (Williams et al. 2003) influence these 
traits. Neuroscientists have long appreciated the con-
text dependence and plasticity of neurotransmitter sys-
tem function. Such complexities, however, limit the ef-
fectiveness of current behavior genetic methodologies 
and analytic strategies. 
Epistasis should be expected between genes in neu-
rotransmitter systems because the resulting proteins in-
teract with each other to produce neural activity (Gri-
gorenko 2003). In the serotonin system, there is some 
empirical evidence that the influence of particular 
polymorphisms is dependent on the genetic and envi-
ronmental context in which they are found. For exam-
ple, the S allele of a polymorphism in the 5-HT trans-
porter regulatory region (5-HTTLPR) is associated with 
a reduction in volume of a region of the anterior cingu-
late except in those individuals who carry a brain de-
rived neurotrophic factor (BDNF) Met allele (Pezawas 
et al. 2008). Another recent study described a complex 
interaction between 5-HTTLPR, monoamine oxidase A 
(MAOA) and catechol-O-methyl transferase (COMT) 
genotype, gender and stress response and susceptibility 
to major depression (Jabbi et al. 2007). These are just two 
examples presented as evidence for epistasis in the path-
ways from neurotransmitter genes to behavior via brain 
circuits. While it is true, as pointed out by a reviewer, 
that these and other specific empirical findings of sta-
tistical epistasis may eventually turn out to be false (Io-
annidis 2005), the inclusion of physiological epistasis in 
models of neurotransmitter systems is likely to enhance 
their realism (Brodie 2000), and may, in fact, be neces-
sary for understanding the systems. 
Dynamic systems modeling
Progress in the characterization of pathways from 
genes to behaviors will require the development of new 
tools and methodologies and will benefit from the appli-
cation of technologies not typically applied to problems 
in behavioral genetics. One approach that is well devel-
oped, but not in a behavior genetics context, is dynamic 
systems modeling. In this article, we present a case for 
the use of dynamic systems modeling in behavior ge-
netics research by presenting and validating a model of 
neurotransmitter genes and function. 
Dynamical system modeling, feedback, filtering and 
signal processing has been applied to biology or bio-
logical engineering for quite some time [for a review of 
concepts relating to modeling, properties of differential 
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equations, stability and controllability issues see Stolten-
berg and Nag (2007)]. Indeed, one of the pioneers of the 
field of biological modeling, Norbert Wiener, formalized 
the ideas of feedback and filtering in biology (Weiner 
1965). He also developed the field of cybernetics which 
is a multidisciplinary study involving control systems 
applications, amongst other fields, to evolutionary biol-
ogy, neuroscience and psychology. Various oscillators 
like Duffing Oscillator, Van der Pol oscillator and Lien-
ard systems has been motivated and used to model car-
diac and neural oscillatory behavior. Finally, dynamical 
system modeling in evolutionary biology was pioneered 
by J. B. S. Haldane where he argued that a systematic 
theory of natural selection must be a quantitative theory 
(Haldane 1924). 
Dynamical system and control theory can contribute 
significantly to the modeling of biological subsystems 
by incorporating multiple parameters whose values 
may depend upon genetic polymorphisms. The advan-
tage in modeling using differential equations and feed-
back control theory is generating hypotheses which can 
then be empirically tested. Moreover, medical advances 
can be made by perturbing certain parameters govern-
ing the dynamics of the subsystem to simulate the ac-
tions of pharmacological agents and studying the over-
all impact on system function prior to conducting costly 
and risky experiments. On the other hand, even though 
in principle detailed modeling of interconnected subsys-
tems is possible, however, there could be multiple bio-
chemical processes whose aggregate effect is currently 
understood but individually the processes are still un-
known. In such cases, the dynamic system model is de-
scribing the average effects rather than modeling the 
detailed intricate subsystems that contribute to the ag-
gregate effects. Also, in some cases since the model pa-
rameters are not known, the control theoretic model 
uses values on per unit basis; however, the output is to-
pologically equivalent to the output of the system if the 
values of the model parameters were known. Thus, in 
the spirit of Henri Poincare, we are interested in qual-
itative analysis and prediction using ordinary differen-
tial equations, rather than actual numerical values of the 
model output. This approach relieves the modeler from 
the responsibility of absolute accuracy in setting param-
eter values because the focus is on relative differences 
and qualitative outcomes. 
We shall introduce two mathematical models as ex-
amples of the application of dynamical system or con-
trol theory to model biological systems. The first model 
we shall present is that of a bistable switch which has 
been studied in great detail in mathematical biology [see 
Cinquin and Demongeot (2002) for details]. The bistable 
switch is used to model cellular differentiation because 
it is a dynamic process in which differentiated cells can 
be in two or more states due to epigenetic regulation for 
example DNA histone acetylation or re-acetylation. Let 
us consider two proteins whose concentration are de-
noted by x 1, x 2. It is usually assumed that each of the 
proteins are undergoing exponential decay and they in-
hibit the synthesis of other proteins in the switch with 
cooperativity of repression c 1, c 2 and rate of synthesis s 
1, s 2. Then the bistable switch can be modeled by the fol-
lowing autonomous differential equations:
dx1 = – x1  +
    s1                                   (1)
                                 dt                  1 + x
2
c2
dx2 = –x2  +
      s2                                  (2)
                                 dt                   1 + x
1
c1
The second model is the well known Predator and Prey 
model described by the set of Lotka–Volterra differen-
tial equations (see Gottman et al. 2002 or Perko 1991 for 
details). Let x1 represent the prey population and x2 rep-
resents the predator population. Then the well known 
Lotka–Volterra equations describing the two competi-
tive species can be written as follows:
dx1 = ax1 – bx12 – cx1x2                               (3)                          dt
dx2 = –ax2 – bx22 – dx1x2                             (4)                          dt
where a > 0 and d ≥ c > b > 0 are constant parame-
ters. It is to be noted that the differential Equations 1–
4 are nonlinear because of the presence of terms such as 
s1/(1+x2c2), x1
2, and x1x2. These systems are usually re-
ferred to as planar systems and their properties can be 
understood by analyzing their phase portrait. 
We shall introduce two mathematical models as ex-
amples of the application of dynamical system or control 
theory to model psychology systems. The first model is 
the well known model describing neurons [see Dunn et 
al. (2004) or Khalil (1996) for more details] as electrical 
circuits. Let xi be the activation level of i th neuron. The 
function σi :  R → (–V, V), where R is the set of real num-
bers, is the i th sigmoidal function with asymptotic ac-
tivation levels −V and V. Let Tij be the synaptic input 
from neurons j to neuron i and li represents a constant 
input usually referred to as static bias. Let τi be the time 
constant which determines how rapidly the activation 
rapidly reaches its steady state value. Then the n neu-
rons circuit can be mathematically modeled as intercon-
nected differential equations,
τi
 dxi  = –xi + ∑ Tij g(xj (t)) + li                            (5)                    dt                 j 
for i = 1 … n.
The second model is a mathematical model describ-
ing marital interaction between husbands and wives 
[see Gottman et al. (2002) for more details]. This dynam-
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ical system model is different from the previous models 
(1)–(4), in the sense that the independent variable time 
takes on discrete value, that is, t = 1, 2, 3, … . Let H(t) 
and W(t) be the husband and wife’s behavior score at 
time t > 0. The influence function IHW (H(t)) is the influ-
ence of husband’s state at time t on wife’s state at time 
t + 1. Similarly, the influence function IWH(W(t)) is the 
influence of wife’s state at time t on husband’s state at 
time t + 1. Then the discrete dynamical system model de-
scribing the marital interaction between husband and 
wife is given as follows
H(t + 1) = IWH (W(t)) + aH(t) + b,                         (6)
W(t + 1) = IHW (H(t)) + cW(t) + d.                       (7)
The parameters a, b, c, and d are constants which are 
usually estimated for each person. The influence func-
tions IHW (H(t)) or  IWH (W(t)) are usually piecewise con-
stant functions or piecewise linear and they depend on 
various issues/factors that influence the marriage. 
From the above examples, and many more that can 
be found in various literature regarding system theo-
retic modeling of biological or psychological processes, 
one of the main points is that dynamic systems model-
ing of cognitive processes and that of neurons and neu-
ral networks, and brain circuits is well-developed, but 
that genetic variation at system components has not 
been modeled yet, with the exception of work from 
our own laboratory (Stoltenberg 2003, 2005, 2010; Stol-
tenberg and Nag 2007). These examples also show that 
the approach can be used to model systems at different 
levels of analysis. To advance in our understanding of 
pathways from genes to behaviors, we need to model 
the effects of genetic polymorphisms on parameters in 
such models. 
Dynamic systems modeling of the serotonin system
Substantial empirical and theoretical evidence im-
plicates variation in the function of the serotonin neu-
rotransmitter system in the etiology of individual dif-
ferences in behavioral control (Carver and Miller 
2006). Candidate gene association studies have iden-
tified polymorphisms in genes that code for enzymes 
involved in serotonin metabolism as being associated 
with impulsive traits (Reuter et al. 2007; Stoltenberg et 
al. 2006) and with behavioral disorders characterized 
by deficient behavioral control (Bondy et al. 2006; Hill 
et al. 2002; Sheehan et al. 2005; Virkkunen et al. 1996). 
Genetic variants in the serotonin system are associated 
with brain volume differences and reactivity in areas 
associated with emotional processing and executive 
control (Canli et al. 2005, 2008; Herrmann et al. 2007; 
Pezawas et al. 2008). Clearly, the serotonin system is an 
important candidate system for understanding the bi-
ology of impulsivity. 
To begin modeling the effects of genetic variation on 
the functioning of a neurotransmitter system, one must 
determine which components of the system to model. 
The components of interest should have known roles 
in controlling aspects of system function. From the per-
spective of a systems approach, one should strive to 
simplify nature while including sufficient complex-
ity to manage the system (Ward 2002). Our primary fo-
cus has been on presynaptic control of serotonin func-
tion, which has kept us, for the moment, from modeling 
postsynaptic outcomes of serotonin function. Presynap-
tic control of serotonin function is sufficiently complex 
to merit such a focus and eventually we plan to extend 
the model to include postsynaptic effects. 
The present model is an extension of an earlier, 
more basic one that included three presynaptic compo-
nents: the 5-HT reuptake transporter and two autore-
ceptors (Stoltenberg 2005). Reuptake via the serotonin 
transporter (SERT) is the primary means by which the 
action of synaptic 5-HT is terminated. The 5-HT1A so-
matodendritic autoreceptor inhibits 5-HT neural firing 
and further 5-HT release when extracellular levels of 5-
HT exceed a threshold. The 5-HT1B terminal autorecep-
tor adjusts the amount of 5-HT to be released. These 
three components contain common genetic polymor-
phisms, play a significant control in 5-HT presynaptic 
function and appear to epistatically interact (Stolten-
berg 2005). 
In this report, we describe our extensions and refine-
ment of the dynamic system model of 5-HT presynap-
tic function. We added two metabolic enzymes to the 
model, (a) tryptophan hydroxylase, which is the rate-
limiting enzyme in serotonin synthesis, and (b) mono-
amine oxidase A, which catalyzes the catabolism of se-
rotonin. The addition of these two components provides 
a much more complete model of 5-HT function, one that 
includes most major aspects of the 5-HT “life cycle” in 
the brain. By including serotonin synthesis and metab-
olism, we will be able to simulate acute tryptophan de-
pletion as well as cerebral spinal fluid levels of the 5-HT 
metabolite 5-hydroxyindoleacetic acid (CSF 5-HIAA), 
both of which provide opportunities for further model 
validation. 
In addition to determining which parameters to 
model, one must determine which outcomes to include. 
In the present case, we modeled aspects of central 5-HT 
function that were directly impacted by components 
of the model and we focused on those indices of 5-HT 
function that would provide avenues for comparison to 
measures in the empirical literature. Specifically, mea-
sures of extracellular (or synaptic) levels of 5-HT are of-
ten measured in mice using microdialysis techniques (de 
Groote et al. 2002; Stenfors and Ross 2004), measures of 
neural firing are measured using single unit recording 
(Sharp et al. 1997) or on a much grosser scale, functional 
magnetic resonance imaging (functional magnetic reso-
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nance imaging) (Hariri and Weinberger 2003), and mea-
sures of CSF 5-HIAA are obtained via lumbar puncture 
(Williams et al. 2003). In our model, we included the fol-
lowing outcome measures: (a) 5-HT cell firing rate; (b) 
extracellular (synaptic) 5-HT level; (c) intracellular 5-HT 
level; and (d) CSF 5-HIAA level. 
Our model is based on the assumption that ge-
netic polymorphisms in system components, as well 
as pharmacological action, produce alterations in as-
pects of neurotransmitter system function (e.g., neu-
ral firing rates, level of synaptic neurotransmitter, level 
of neurotransmitter metabolites in the cerebral spinal 
fluid) in an interactive fashion. Moreover, we assume 
that these variations in system function produce struc-
tural or functional differences in brain regions that in-
fluence the behaviors of interest. Whether these as-
sumptions are supported by empirical findings at this 
point in time is immaterial to this modeling work. We 
assume that such genetic variation exists or alterna-
tively that pharmacological intervention can produce 
the differences in function that we are modeling. Based 
on empirical evidence, epistasis, gene by environment 
interactions and gender moderation of neurotransmit-
ter function are expected. In this study, we describe a 
control system model of presynaptic serotonin func-




In the following sections we describe our control sys-
tem model of presynaptic serotonin function, which 
consists of a series of differential equations. Several of 
the equations are modifications of our previous work 
and others are slight modifications of well known equa-
tions that model enzyme kinetics. In each case, a single 
parameter models genetically mediated functional vari-
ation from “low” to “high” across a range of values opti-
mized to influence one or more of the outcome variables. 
Such parameter optimization is necessary in model de-
velopment and is a first step in establishing the face va-
lidity of the model. 
Intracellular and extracellular serotonin dynamics
In this section, we describe the equations used to 
model the action-potential mediated release of 5-HT 
into the synapse as well as 5-HT reuptake mediated by 
the serotonin transporter. Our model is based on known 
functions of 5-HT system components including autore-
ceptor mediated firing inhibition and release, refractory 
periods and reuptake (Baumgarten and Gothert 1999). 
To our knowledge, no standard differential equations 
exist for these functions. The equation that models extra-
cellular 5-HT level simply describes the amount of extra-
cellular 5-HT at a given time is a function of how much 
enters the synapse via release and exits via reuptake and 
diffusion. The equation that models intracellular 5-HT 
levels simply describes the amount of intracellular 5-
HT at a given time is a function of how much enters the 
presynaptic neuron via synthesis and reuptake and how 
much exits the neuron via release and catabolism. 
Let x1(t) be the amount of extracellular serotonin com-
partment at any time t > 0. Let γ be the reuptake rate pa-
rameter whose value is influenced by an individual’s 5-
HTTLPR genotype. Let δ be the diffusion rate coefficient 
which characterizes the loss of serotonin from the extra-
cellular serotonin compartment. The numerical value of 
δ is usually very small. 
Let u(t) be the feedback control input to the extracellu-
lar serotonin compartment. The signal u(t) is a compos-
ite of output of the autoreceptors 5-HT1A, 5-HT1B the 
refractory period and the amount of intracellular se-
rotonin x2(t) in the intracellular compartment (see Fig-
ure 1). The refractory period is modeled by a sinusoidal 
function whose period can be modulated. All the con-
trol inputs from the autoreceptors 5-HT1A and 5-HT1B 
are non-zero during the positive part of the refractory 
period, thus allowing the neurons to fire. The autore-
ceptor 5-HT1A inhibits the firing of serotonin contain-
ing neurons if the level of extracellular serotonin x1(t) is 
greater than the set point value of serotonin x1th. Thus, 
the feedback u(t) contains the activation or inhibition 
function for set point regulation or homeostasis. The func-

























Figure 1. Flow diagram of presynaptic control elements in 
the serotonin system. Dietary tryptophan is converted to se-
rotonin by TPH2 and stored in the intracellular compartment. 
Serotonin is released into the synapse as a function of a refrac-
tory period and input from two autoreceptors that inhibit fir-
ing (5-HT1A) or influence the amount of serotonin released 
(5-HT1B). Serotonin is removed from the synaptic space by the 
serotonin transporter (SERT) via reuptake. Serotonin is either 
repackaged for re-release or it is catabolized by MAOA and its 
by product 5-HIAA is transported to the cerebral spinal fluid 
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takes on random values in the interval (0,1) and there 
is a parameter aprob whose numerical value if equal 
to one implies normal functioning of the autoreceptor 
and any other value in the interval (0,1) will lead to 
stochastic inhibition to the firing rate (i.e., modeling 
inefficient firing inhibition). The autoreceptor 5-HT1B 
determines the amount of release of serotonin when 
activated. The autoreceptor 5-HT1B is modeled by two 
parameters Rmax which is the maximum amount of 
serotonin release in per unit from intracellular com-
partment and β a constant parameter (for a given 
genotype) which models the proportion of extracel-
lular serotonin present at any time in the extracellu-
lar compartment such that Rmax – βx1(t) is the propor-
tion of serotonin input to the synapse. This controller 
design is adopted so as to avoid excess serotonin in 
the synapse. Moreover, when the autoreceptor 5-HT1B 
is not working at all (e.g., “knocked out”) then β = 0, 
and when it is fully functioning then β = 1. Genetic or 
pharmacological variation can be modeled such that 
β ∈ (0,1). Thus, the resultant control function of re-
fractory period, 5-HT1A and 5-HT1B is mathematically 
modeled as follows,
               0                       if sin (  tper) ≤ 0
 u(t) = {  0                       if sin (  tper) > 0 & rand > 1 – aprob                                            & x1 – x1th > 0
              (Rmax – βx1)x2   if sin (  tper) > 0 & rand > 1 – aprob
                                            & x1 – x1th ≤ 0                          
 (8)
where the parameter per modulates the refractory 
period. 
We also model the feedback input u(t) to the extra-
cellular serotonin compartment by using input–output 
characteristic of the sigmoidal function such that there 
is a gradual build up of extracellular serotonin x1(t) 
with a growth rate of τ/2, which is fixed a priori in the 
model simulation. Thus, the feedback input to the syn-
apse is modeled as a “gate” which has delay or time lag 
of τ/2 for the serotonin to build up to the final state in-
stead of a “light switch” [see Sontag (2005) for details 
regarding sigmoidal response] which is usually mod-
eled by a step function. The input–output sigmoidal 
function is given by, 
 s(x2(t)) =  
1 – ε–τx2(t)
                  1 + ε–τx2(t)
Thus, the dynamics of extracellular serotonin compo-
nent is given by,
dx1(t) = – (γ + δ)x1(t) + u(t)s(x2(t)).               (9)                        dt
The intracellular serotonin dynamics is modeled as 
follows,
dx2(t) = – κ4x2(t) + γx1(t) + ρ(t) – u(t),                  (10)              dt
where κ4 is a positive constant which is the coupling rate 
that causes metabolic breakdown of serotonin through 
the involvement of the enzyme monoamine oxidase A 
(MAOA), ρ(t) is a state variable which corresponds to 
the serotonin input to the intracellular serotonin com-
partment produced from dietary tryptophan catalyzed 
by a type of rate-limiting enzyme tryptophan hydroxy-
lase which has been identified as TPH2 and u(t) is given 
by Equation 8. 
Serotonin synthesis
Equations describing enzyme kinetics are well 
known, and in this section and the next we describe our 
minor modifications of those equations to model geneti-
cally mediated functional variation in enzyme function. 
In both sets of equations we assume that genetic vari-
ation influences the rate at which the enzyme converts 
substrate to product. 
We mathematically model the conversion of dietary 
tryptophan into serotonin by the application of the 
rate-limiting enzyme TPH2 by modifying the Michae-
lis–Menten kinetics model (see Edelstein-Keshet 1988 
for more details). Let c(t) be the amount of tryptophan 
from diet in the synthesis chamber and υ be the con-
stant amount of tryptophan input from the reservoir 
(see Figure 1). Let κ–1 be a positive coefficient indicat-
ing reverse reaction rate and κ1trp be a positive con-
stant indicating forward reaction rate. Then the rate 
of change of tryptophan in the synthesis chamber is 
given by
dc(t) 
= – c(t) +
 (  κ–1  + c(t) ) y1(t) + υ                     (11)       dt                       κ1trp
where y1(t) is the amount of TRP-TPH2 complex. Let ε 
be a singular perturbation coefficient which is relatively 
small indicating a very slow, quasi-static change of the 
TRP-TPH2 complex and κ2trp a positive number mod-
eling the synthesis rate coefficient. Then, the rate of 
change of the TRP-TPH2 complex is given by
ε
 dy1(t) = c(t) –
 ( κ–1 + κ2trp  + c(t) ) y1(t)                    (12)          dt                          κ1trp
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Finally, the rate of production of serotonin by catalysis 
of TRP-TPH2 complex is given by
dρ(t) 
= –κ3 ρ(t) + κ2trp y1(t)                               (13)                     dt
where κ3 is a positive constant which is designed for as-
ymptotic stabilization. 
Serotonin catabolism
We shall model the metabolic breakdown of sero-
tonin by the enzyme MAOA by applying very similar 
technique as was discussed in the context of conver-
sion of dietary tryptophan into serotonin. Let λ(t) be the 
amount of serotonin involved in the metabolic break-
down in the catabolic chamber (see Figure 1) and z1(t) 
be the 5-HT-MAOA complex. Let κ1maoa is a positive con-
stant indicating forward reaction rate. Then, we have 
the following,
dλ(t) 
= – λ(t) +
 (   κ–1   + λ(t) ) z1(t) + κ4x2(t) .           (14)        dt                        κ1maoa
Let κ2maoa be a positive number modeling the metabolic 
rate coefficient. Then, the rate of change of the 5-HT-
MAOA complex is given by,
ε
 dz1(t) =  λ(t) –
 ( κ–1 + κ2maoa + λ(t) ) z1(t) .           (15)               dt                        κ1maoa
Finally, the rate of production of CSF 5-HIAA is given 
by
dp(t) 
= – κ3p(t) + κ2maoa z1(t) ,                          (16)                    dt
where, p(t) is the amount of CSF 5-HIAA at any time 
t > 0.
Firing rate
An important outcome measure for mathematical 
models of neurons is the number of action potentials in 
a given time period. Such an outcome is a representation 
of neural activity, which can then be compared to empir-
ical observations of single unit recordings or more gross 
measures of brain activation such as EEG or MRI. In 
our model, we are measuring the number of times that 
the system “fires” or releases 5-HT in a fixed number of 
time steps (i.e., 200, with a dt = .01). So, in this study, the 
maximum number of times that a system could fire is 
20,000 (i.e., 200/.01). 
We integrate Equations 8–16 using the Runge–Kutta-
4 routine of Berkeley Madonna 8.0.1 with a pre-deter-
mined step size of  Δt > 0. To measure the firing rate we 
define the following discrete dynamical equation,
FIRERATE(t + Δt) = FIRERATE(t) + FIRE(t), t ≥ 0      (17)
where FIRE(t) = { 1    if u > 0
                                
0    otherwise
and FIRERATE(t) is a discrete variable which mea-
sures the firing rate of the neuron. The discrete dynam-
ical Equation 17 is initialized by FIRERATE(0) = 0 and 
FIRE(0) = 0. 
Software
To solve the systems of differential equations, we used 
Berkeley Madonna 8.0.1 (Zahnley et al. 2001). The code 
for the model and the basic model parameters are in-
cluded in the Appendix. 
Model validation
To test the validity of the model, we conducted three 
separate tests. The first validity test examined the face 
validity of the model by comparing parameter plots to 
empirical or theoretical expectations of parameter varia-
tion for the five primary model components (a) synthe-
sis [tryptophan hydroxylase], κ1trp, (b) release threshold 
[5-HT1A], aprob, (c) release quantity [5-HT1B], β, (d) reup-
take [5-HTTLPR], γ, and (e) catabolism [MAOA], κ1maoa. 
Each parameter was varied across a range of values that 
represented “low” to “high” function. For each parame-
ter, plots were generated for each outcome of interest (a) 
firing rate, (b) synaptic 5-HT level, (c) intracellular 5-HT 
level and, (d) CSF 5-HIAA level. It should be noted that 
we optimized each parameter so that varying it across 
the range of low to high function produced noticeable 
changes on at least one outcome variable. Such an ap-
proach is necessary at the early stages of model devel-
opment because the appropriate scale for parameters is 
not obvious a priori. Therefore, these tests of face valid-
ity indicate simply that when the parameter of interest 
is varied across a given range of values it influences a 
given outcome in a direction that fits with a general un-
derstanding of how the system functions. 
The second validity test examined criterion validity 
of the model by comparing model output to empirical 
reports of brain activity for individuals with different 
genotypes for TPH2 and 5-HTTLPR (Canli et al. 2008). 
We simulated firing rate data for nine groups defined 
by combinations of “low”, “medium,” and “high” lev-
els of the synthesis (TPH2) and reuptake parameters (5-
HTTLPR). This test is an attempt to determine whether 
the model is capable of producing a pattern of output 
that is similar to a recent finding that identifies an asso-
ciation between genotype and patterns of brain activa-
tion. If the model produces output patterns that are gen-
erally similar to empirical findings it suggests that the 
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model is capturing some important aspects of 5-HT sys-
tem function. 
The third validity test examined criterion validity 
of the model by comparing a model outcome to an ob-
served measure of impulsivity in groups of subjects de-
fined by their THP2 intron-8 (rs1386483) and MAOA (u-
VNTR) genotypes. Subjects completed a questionnaire 
measure of impulsivity and provided buccal cells for 
DNA extraction and PCR-based genotyping. We simu-
lated CSF 5-HIAA data for four groups defined by “low” 
and “high” levels of synthesis (TPH2) and catabolism 
(MAOA) parameters. Individuals were assigned simu-
lated CSF 5-HIAA values based on their joint genotypes 
(“low” synthesis = TPH2 C/C; “high” synthesis = TPH2 
T/_; “low” catabolism = MAOA short [i.e., presence of 
3-repeat]; “high” catabolism = MAOA long). We chose 
to examine simulated CSF 5-HIAA level with impul-
sivity because of the well documented negative correla-
tion between them (Soderstrom et al. 2001; Westergaard 
et al. 2003). We focused on TPH2 and MAOA because in 
the face validity tests both the synthesis and catabolism 
parameters influenced CSF 5-HIAA level. This is an at-
tempt to determine whether the model is capable of pre-
dicting an individual’s self-reported impulsivity based 
solely on their genotype at two loci. An important as-
pect of a systems behavior genetic approach is to im-
prove our ability to predict behavior based on an indi-
vidual’s genotype. We do not have observed levels of 
CSF 5-HIAA in this dataset. It would be desirable to first 
test whether our simulated levels of CSF 5-HIAA deter-
mined by genotype were associated with actual CSF 5-
HIAA levels. However, lumbar punctures were outside 
of the scope of this study. Therefore, in an exploratory 
analysis, we compared simulated CSF 5-HIAA with ob-
served impulsivity scores as a way to examine the po-
tential of the model to predict behavior. 
Subjects
Subjects who provided data for the third validation 
tests were recruited for another study to examine po-
tential associations between polymorphisms in seroto-
nergic genes and individual differences in impulsivity 
and health-risk behaviors (Stoltenberg et al. 2008). Sub-
jects (N = 200) were recruited from the student popu-
lation at a small midwestern university and were paid 
$5 for their participation. The sample was mostly Cau-
casian (95%), female (62%), and ranged in age from 18 
to 47 (M = 22.67, SD = 5.65). The Institutional Review 
Board approved the study and all subjects provided in-
formed consent. 
Measures
Barratt Impulsiveness Scale (version 11). The Bar-
ratt Impulsiveness Scale, Version 11 (BIS-11) is a widely 
used 30-item questionnaire that assesses levels of impul-
sivity. Higher scores on the BIS-11 denote higher levels 
of impulsivity. Internal consistency of BIS-11 Total score 
for college students is acceptable (Cronbach’s α = 0.82, 
(Patton et al. 1995)). 
Genotyping
DNA was extracted for genotyping from buccal cells 
(DNeasy Blood & Tissue Kit®, QIAGEN®). Gene ampli-
fication was performed on an GeneAmp® PCR System 
9700 (Applied Biosystems), and a FOTO/Analyst Digi-
tal Imaging System (FOTODYNE®) was used to docu-
ment gels stained with Ethidium Bromide and visual-
ized under ultraviolet light. 
The TPH2 intron-8 (rs1386483) polymorphism was 
amplified using forward primer: 5′-GCT GGC TCT 
GAA CGT GTA TTT TG-3′, and reverse primer: 5′-TTT 
GGC TGA TTT TCC TAA TTA AT-3′ (note this primer 
was designed with a mismatched base pair A to gen-
erate an Ssp1 restriction site, (Stoltenberg et al. 2006). 
PCR conditions were 60 s at 95°C, 45 s at 52°C, and 
45 s at 72°C for 30 cycles. To ensure complete diges-
tion, PCR products were digested (in same tube used 
for PCR) overnight with 3–5 units of Ssp1 and then 8 μl 
of each digest was separated by electrophoresis in 3.5% 
agarose gels. 
The MAOA u-VNTR was amplified using forward 
primer 5′-ACA GCC TGA CCG TGG AGA AG-3′, and 
reverse primer 5′-GAA CGG ACG CTC CAT TCG GA-
3′ (Huang et al. 2004). PCR reaction conditions were 
60 s at 95°C, 45 s at 55°C, and 90 s at 72°C for 32 cycles. 




Parameter plots are shown in Figure 2 across a range 
of synthesis rates to model variation in TPH2 activ-
ity (from 1.0 to 2.0) for (a) firing rate, (b) synaptic 5-HT 
level, (c) intracellular 5-HT level and (d) CSF 5-HIAA 
level. As synthesis rate increased, firing rates dimin-
ished. No substantial change in Synaptic level of 5-HT 
was observed. Dramatic increases for both Intracellular 
5-HT and CSF 5-HIAA levels were observed. 
Parameter plots are shown in Figure 3 across a range 
of inhibition probabilities to model variation in capacity 
of the 5-HT1A receptor to inhibit firing (from 0.9 to 1.0) 
for (a) firing rate, (b) synaptic 5-HT level, (c) intracellu-
lar 5-HT level and (d) CSF 5-HIAA level. As the prob-
ability of firing inhibition increased, firing rates drasti-
cally diminished. With the exception of a slight initial 
decrease, no substantial change in Synaptic level of 5-
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HT was observed. No change was observed for both In-
tracellular 5-HT and CSF 5-HIAA levels. 
Parameter plots are shown in Figure 4 across a range 
of release parameters to model variation in capacity of 
the 5-HT1B receptor to control release amount (from 0.0 
to 1.0) for (a) firing rate, (b) synaptic 5-HT level, (c) in-
tracellular 5-HT level and (d) CSF 5-HIAA level. As the 
release parameter increased, firing rates increased. No 
substantial change in was observed for Synaptic level of 
5-HT, Intracellular 5-HT level and CSF 5-HIAA level. 
Parameter plots are shown in Figure 5 across a range 
of reuptake rates to model variation in capacity of the 5-
HT transporter to remove 5-HT from the synapse (from 
0.0 to 1.0) for (a) firing rate, (b) synaptic 5-HT level, (c) 
intracellular 5-HT level and (d) CSF 5-HIAA level. As 
reuptake rate increased, firing rates increased. A dra-
Figure 2. Parameter plots of synthesis rate (i.e., TPH2) show-
ing simulated a) firing rate, b) synaptic 5-HT level, c) intracel-
lular 5-HT level, and d) CSF 5-HIAA level. 
Figure 3. Parameter plots of probability of inhibition (i.e., 5-
HT1A) showing simulated a) firing rate, b) synaptic 5-HT level, 
c) intracellular 5-HT level, and d) CSF 5-HIAA level. 
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matic decrease in Synaptic level of 5-HT was observed. 
No change was observed for both Intracellular 5-HT and 
CSF 5-HIAA levels. 
Parameter plots are shown in Figure 6 across a range 
of catabolism rates to model variation in capacity of 
MAOA to degrade 5-HT (from 1.0 to 2.0) for (a) firing 
rate, (b) synaptic 5-HT level, (c) intracellular 5-HT level 
and (d) CSF 5-HIAA level. As catabolism rates increased, 
no change was observed for firing rates, Synaptic or In-
tracellular levels of 5-HT. A substantial increase in CSF 5-
HIAA levels was observed as catabolism rates increased. 
Simulated firing rate by TPH2 and 5-HTTLPR genotype
Figure 7a shows simulated firing rates for nine gen-
otypes defined by level of function for the synthesis 
Figure 4. Parameter plots of release amount (i.e., 5-HT1B) show-
ing simulated a) firing rate, b) synaptic 5-HT level, c) intracel-
lular 5-HT level, and d) CSF 5-HIAA level. 
Figure 5. Parameter plots of reuptake rate (i.e., SERT) showing 
simulated a) firing rate, b) synaptic 5-HT level, c) intracellular 
5-HT level, and d) CSF 5-HIAA level. 

















































(TPH2) and reuptake (5-HTTLPR) parameters. Synthe-
sis rates (TPH2) were modeled as High (TT, 2.0), Me-
dium (TG, 1.5), and Low (GG, 1.0). Reuptake rates (5-
HTTLPR) were modeled as High (LL, 1.0), Medium (LS, 
0.5), and Low (SS, 0.0). The lowest firing rates are ob-
served in the Low reuptake condition, with very little 
difference observed due to synthesis rates when cou-


































Medium or High, firing rates also increase. In addition, 
within Medium or High reuptake groups, firing rate is 
highest for the Low synthesis conditions and lowest for 
the High synthesis conditions with the Medium synthe-
sis condition intermediate. The non-parallel lines shown 
in Figure 7a indicate epistatic interaction between TPH2 
and 5-HTTLPR on firing rate. 
Figure 7b shows the nine genotypes combined into 
the three groups that were compared with respect to 
brain activation in response to emotional stimuli (Canli 
et al. 2008). Grouping the genotypes in that way pro-
duced a graph that suggests an additive relationship for 
TPH2 and 5-HTTLPR on firing rate. Our results suggest 
that the model captures the relationship between TPH2 
and 5-HTTLPR genotypes on firing rate such that higher 
rates of 5-HT firing are associated with lower levels of 
brain activation in response to affective stimuli. In other 
words, higher rates of 5-HT firing produce a higher level 
of constraint on the amygdala. Additionally, our simula-
tion results suggest that TPH2 and 5-HTTLPR may actu-
ally epistatically interact to affect brain activation in re-
sponse to emotional stimuli and that the grouping used 
by Canli et al. (2008) may have obscured the interaction. 
Figure 6. Parameter plots of catabolism rate (i.e.,. MOAA) 
showing simulated a) firing rate, b) synaptic 5-HT level, c) in-
tracellular 5-HT level, and d) CSF 5-HIAA level. 
Figure 7. Simulated firing rate of serotonergic neurons across 
groups defined by 5-HTTLPR and TPH2 genotypes shown 
in a) separate genotype groups, and b) pooled groups after 
Canli et al. (2008) [i.e., L + G = L/L, G/G; L + T = L/L, T/_
; S + G = S/_, G/G; S + T = S/_, T/_]. The pattern of effects 
shown in panel B is consistent with the additive effect reported 
by Canli et al. (2008) although the underlying pattern shown in 
panel A (i.e., the raw scores before grouping) suggests epista-
sis not additivity. 
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Simulated CSF 5-HIAA and impulsivity
TPH2 allele frequencies were calculated by pool-
ing across sex. Because the MAOA u-VNTR is X-
linked, allele frequencies were analyzed separately by 
sex. For TPH2 (intron-8; rs1386483): C (142 bp) = 0.73, 
T (123 bp) = 0.27 (N = 189); for MAOA u-VNTR: for 
males, 3-repeat (321 bp) = 0.42, 4-repeat (351 bp) = 0.57, 
5-repeat (381 bp) = 0.01 (N = 69); for females, 3-re-
peat = 0.37, 4-repeat = 0.61, 5-repeat = 0.02 (N = 124). All 
markers were in H–W equilibrium. Due to small sam-
ple sizes in some cells and because of documented ac-
tivity differences associated with MAOA u-VNTR gen-
otype (Deckert et al. 1999) we grouped the sample into 
four genotype categories defined by TPH2 (T/_ and C/
C) and MAOA (Short = 3-repeat homo- or hemizygotes, 
Long = all others). Analyses were conducted using data 
from the 187 individuals that had both genotypes and 
BIS-11 scores available. 
The mean score for the observed BIS-11 Total was 
62.86 (SD = 9.83, N = 187). The mean level for the sim-
ulated CSF 5-HIAA was 2.68 (SD = 1.08, N = 187). Z-
scores of the observed BIS-11 Total score and the sim-
ulated CSF 5-HIAA level were significantly correlated 
(r = −0.22, p = .002). Figure 8 shows observed mean BIS-
11 Total scores and simulated mean CSF 5-HIAA lev-




We modeled the effects of genetic polymorphisms in 
controlling components of presynaptic serotonin neu-
rotransmitter function with a control system model 
consisting of differential equations and difference 
Equations 8–17 and tested the validity of the model by 
comparing its output with both published empirical 
reports and with observed genetic and questionnaire 
data. Basic validation tests, such as observing increases 
in simulated extracellular 5-HT levels when the reup-
take parameter is reduced, suggest that the model cap-
tures aspects of 5-HT function. Further validation of 
the model was obtained by comparing simulation re-
sults to a published empirical report of the association 
between TPH2 and 5-HTTLPR genotypes on brain ac-
tivity in response to observing facial expressions of fear 
(Canli et al. 2008). Interestingly, our results suggest that 
the genotype grouping used by Canli et al. (2008) may 
have limited their capacity to detect potential epistatic 
interaction between TPH2 and 5-HTTLPR. Further-
more, the model was validated by simulating the CSF 
5-HIAA levels of individuals based on their TPH2 and 
MAOA genotypes and observing a negative correla-
tion between the simulated CSF 5-HIAA and observed 
impulsivity scores as measured by the Barratt Impul-
siveness Scale. At this juncture, it is important to note 
that further validation tests of the model should be 
conducted, but the validation tests presented here pro-
vide important, albeit indirect, evidence that the model 
captures important aspects of the influence of genetic 
polymorphisms on 5-HT system function. More direct 
validation tests with both human and non-human an-
imal models and direct measures of 5-HT function are 
needed. 
Reducing the synthesis parameter (from 2.0 to 1.0) in 
our face validity tests produced an increase in the rate of 
neural firing and significant decreases in intracellular 5-
HT and CSF 5-HIAA (see Figure 2). A change in the rate 
of neural firing is consistent with the interpretation that 
vesicles are less than full when the rate of 5-HT synthe-
sis is reduced, which then requires more firing events to 
achieve sufficient synaptic 5-HT levels. A reduction in 
intracellular 5-HT is consistent with a recent study that 
found serotonergic neurons in the raphe nucleus to be 
devoid of 5-HT in mice with the TPH2 gene knocked 
out (Gutknecht et al. 2008). Our parameter range did not 
model a complete knockout of TPH2, but our results are 
consistent in the sense that a reduction of synthesis pro-
duced a reduction in intracellular levels of 5-HT. We did 
not see a reduction in extracellular 5-HT, which is likely 
due to the fact that we did not model a complete knock-
out of synthesis and that even when intracellular levels 
are relatively low they are sufficient to maintain suffi-
cient 5-HT in the extracellular space. Our finding, that 
reducing synthesis also reduces CSF 5-HIAA levels is 
not consistent with a recent study that found no asso-
ciation between variants of a TPH2 promoter single nu-
cleotide polymorphism (SNP) rs4131347 (–C8347G) and 
CSF 5-HIAA (Mann et al. 2008). It is not clear, however, 
whether this particular SNP is associated with signifi-
cant differences in 5-HT synthesis. Our findings suggest 
that significant changes in 5-HT synthesis are likely to 
be associated with CSF 5-HIAA levels. 
Figure 8. Mean observed BIS-11 Total scores and simulated 
CSF 5-HIAA levels for subjects grouped by observed MAOA 
and TPH2 genotypes.
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The primary effect of reducing the probability of in-
hibition, which models a reduction in 5-HT1A autore-
ceptor function, is an increase in neural firing rate (see 
Figure 3). Consistent with our earlier work (Stoltenberg 
2005), our present findings for modeling the 5-HT1A au-
toreceptor correspond to work with 5-HT1A knockout 
mice that show a significant increase in 5-HT neural fir-
ing rates (He et al. 2001; Parsons et al. 2001; Richer et al. 
2002) and little to no change in extracellular 5-HT levels 
(He et al. 2001; Parsons et al. 2001; Richer et al. 2002). 
Varying the release parameter, which models varia-
tion in the efficiency of the 5-HT1B terminal autorecep-
tor to adjust the amount of 5-HT released in response to 
an action potential, affected only firing rate in our study 
(see Figure 4). Reducing the release parameter from its 
baseline of 1.0–0.0 produced a substantial decrease in 
neural firing rate because without the capacity to reduce 
the amount of 5-HT released from the maximum results 
in excess 5-HT in the synapse, which then results in fir-
ing inhibition via the 5-HT1A autoreceptor. The firing 
rate of 5-HT containing neurons in the dorsal raphe is 
reduced in 5-HT1B knockouts relative to wild type (Ev-
rard et al. 1999). 
Varying the reuptake rate parameter in the present 
study modeled variation that could result from genetic 
polymorphisms, such as 5-HTTLPR, or by pharmaco-
logical intervention, such as selective serotonin reuptake 
inhibitors. Reducing reuptake from its baseline value of 
1.0–0.0 increased the level of extracellular 5-HT and re-
duced the firing rate (see Figure 5). Both of these effects 
are seen in mice, whose reuptake rate is manipulated by 
knocking out the 5-HTT structural gene or by adminis-
tration of SSRI (de Groote et al. 2002; Evrard et al. 2002; 
Gobbi et al. 2001; Mannoury la Cour et al. 2001). We did 
not observe changes in levels of intracellular 5-HT or 
in CSF 5-HIAA. However, there is evidence that 5-HT-
TLPR genotype may be associated with differences CSF 
5-HIAA levels (van der Stelt et al. 2004; Williams et al. 
2003). Our model does not capture this aspect of 5-HT 
function, which suggests that further refinements to the 
model are necessary. 
Varying the catabolic parameter in the present study 
modeled variation that could result from genetic poly-
morphism, such as the MAOA u-VNTR, or pharmaco-
logical intervention, such as a monoamine oxidase in-
hibitor. Such variation in the model produced changes 
in only CSF 5-HIAA level (see Figure 6). There is evi-
dence that the MAOA u-VNTR genotype affects CSF 5-
HIAA level, but that the outcome may depend on gen-
der (Jonsson et al. 2000). We will extend the model to 
include gender so that we can better describe the func-
tion of the system. 
For the most part, the model produces output that 
has substantial face validity. That is not to say, however, 
that the model cannot be improved. It does appear to 
capture important aspects of 5-HT system function. 
In our tests of criterion validity, we compared the 
output of the model to specific conditions of inter-
est. In the first case, we found that the pattern of fir-
ing rates across groups defined by High, Medium and 
Low rates of both synthesis and reuptake was consis-
tent with the constraining role that 5-HT neurons play 
on amygdala activation. That is, higher 5-HT firing 
rates should be associated with lower rates of amyg-
dala activation. We found that the group characterized 
by Low synthesis and High reuptake (L + G, see Fig-
ure 7) had the highest firing rate and the group char-
acterized by High Synthesis and Low reuptake had 
the lowest firing rate (S + T) and the remaining group 
(L + T and S + G) was intermediate. This pattern can 
be interpreted in the context of the findings of recent 
amygdala activation patterns in response to facial ex-
pressions of fear where the L + G group had the low-
est activation, the S + T group had the highest activa-
tion and the remaining group was intermediate (Canli 
et al. 2008). Our results suggest the testable hypothesis 
that the G allele of the −703 G/T TPH2 polymorphism 
is associated with low synthesis rates and the T allele is 
associated with high synthesis rates. We were unable 
to locate any extant studies to support this prediction. 
The results of this criterion validity test should provide 
a level of confidence in the model. 
In addition, we preformed another criterion valid-
ity test in which we compared the simulated level of 
CSF 5-HIAA for groups of subjects defined by TPH2 
intron-8 and MAOA u-VNTR genotypes to observed 
scores on the Barratt Impulsiveness Scale (Version 11; 
see Figure 8). The significant negative correlation be-
tween simulated CSF 5-HIAA scores and the impulsiv-
ity scores is consistent with the negative correlation in 
rhesus macaques between CSF 5-HIAA and rate of long 
(i.e., risky) leaps through the tree canopy (Westergaard 
et al. 2003) and outward directed aggression (i.e., im-
pulsive aggression) in humans (Soderstrom et al. 2001). 
Because of the indirect nature of the evidence, this test 
should be considered to be exploratory. It would be 
highly desirable to directly measure CSF 5-HIAA in 
such a study. 
Although serotonin is known to play a role in many 
behaviors and behavioral disorders, it is difficult to di-
rectly measure serotonin function in the human brain. 
Levels of extracellular serotonin are relatively low and 
indirect measures, such as whole blood serotonin lev-
els, may not be good indicators of central serotonin 
function. No analog for single unit recording to mea-
sure firing rates of serotonergic neurons or microdialy-
sis of extracellular serotonin levels is available for use 
in humans. Several indirect measures of serotonin func-
tion have been used in humans such as whole blood or 
plasma serotonin level, binding of receptors or trans-
porters in blood platelets, CSF 5-HIAA, and fMRI. Each 
of these indirect measures of serotonin function has both 
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advantages and limitations. Ideally, a measure of sero-
tonin function would be valid, reliable, simple to mea-
sure, non-invasive and inexpensive. If this control sys-
tem model could provide valid simulated measures of 
central 5-HT function by using genotypes, which can 
be obtained using non-invasive and relatively inexpen-
sive techniques, it would be useful tool in both the re-
search laboratory and the clinic for better understand-
ing and treating disorders that result from 5-HT system 
dysfunction. 
Control system models, such as the one presented 
here may be useful in behavior-genetic analyses be-
cause they provide a platform on which to develop a 
more rich understanding of how genetic variation may 
contribute to individual differences in the function of 
neurotransmitter systems and brain circuits. Candidate 
gene association studies are commonly used to inves-
tigate heredity-behavior relations in humans in a hy-
pothesis driven manner. The case–control approach 
can be used to study genetic associations with disor-
ders or other dichotomous traits. A regression-based 
approach can be used to study associations between 
genetic polymorphisms and the expression of dimen-
sional traits. Although candidate gene association 
studies are widely used, they have been criticized for 
a paucity of replication across studies (Sullivan 2007). 
Population stratification has long been a focus of crit-
icism of case–control designs (Hamer and Sirota 2000) 
although it may not be as critical as once thought, es-
pecially if studies are carefully designed (Hutchison et 
al. 2004). 
Using an approach to the study of heredity-behavior 
relations that incorporates a dynamical systems model-
ing is consistent with the recommendations provided 
by Hutchison et al. (2004) to maximize effect sizes and 
improve the explanatory power of candidate gene as-
sociation studies. Their first recommendation is to use 
a design that controls for third variables. Our proposed 
model explicitly identifies components of the 5-HT sys-
tem that are known to influence its function. While the 
risk for confounding variables exists in any model, a 
theoretically and empirically derived dynamic systems 
model seeks to include the factors that are known to 
significantly influence function thereby reducing the 
number of unknown third variables. This is especially 
true when one compares the dynamic systems ap-
proach to a candidate gene analysis of a single poly-
morphism. Hutchison et al.’s (2004) second recommen-
dation is to use continuous rather than dichotomous 
outcome measures. Such an approach fits well within 
the framework of a dynamic systems approach. Their 
third recommendation is to use an endophenotypes be-
cause such traits will be simpler genetically than will 
diagnoses. In addition, they suggest using quasi-ex-
perimental designs that include assigning individuals 
to groups based on their genotypes in a pretest post-
test design. The model that we describe can be used to 
identify genotype combinations that produce the most 
divergent 5-HT function outcomes. One could screen 
a large sample of individuals to obtain groups of in-
dividuals with the target genotypes and then pheno-
type those individuals in detail. By using this approach 
with well-validated, reliable, continuous psychologi-
cal or physiological measures one could maximize ef-
fect sizes and minimize the number of individuals that 
would be studied intensely. Hutchison et al.’s (2004) 
fourth recommendation was to specify a theoretically 
motivated mediational model. Our system dynamic 
approach clearly fits with this recommendation in that 
our model is based on theoretical and empirical rela-
tions among 5-HT system components. Finally, Hutchi-
son et al. (2004) recommend that researchers provide ef-
fect size estimates and increase sample sizes of studies. 
Our approach, while not specifically addressing this fi-
nal recommendation, is not conflict with it. It is our po-
sition that an approach to studying heredity-behavior 
relations that includes a dynamic systems approach 
to candidate gene association studies would conform 
to the recommendations of Hutchison et al. (2004) and 
thereby increase the reliability of candidate gene asso-
ciation studies. 
There are some limitations to the present model. The 
model does not include a number of factors known to 
influence serotonin function such as gender (Weiss et al. 
2005; Williams et al. 2003), and stress (Barr et al. 2003a, 
b; Caspi et al. 2003; Konno et al. 2007). Not all effects re-
ported in the empirical literature are not reflected in the 
simulation output such as the approximately 30% re-
duction in CSF 5-HIAA that is seen when reuptake is re-
duced (Stenfors and Ross 2004) although this might be 
due to relatively course scaling that might not detect a 
change of that magnitude. Alternatively, it may be that 
our current model might not yet fully capture the com-
plex relations among aspects of 5-HT function. No post-
synaptic effects or interactions with other neurotrans-
mitter systems are included in the present model. These 
and other shortcomings of the model do not detract 
from the demonstrated validity of the model to cap-
ture specific aspects of 5-HT function, but underscore 
the real complexity inherent in pathways from genes to 
behavior. 
Undoubtedly there are alternative approaches to 
modeling the influence of genetic variation on pre-
synaptic 5-HT function. The control system approach 
that we have chosen has a long history, is well under-
stood and provides a powerful and versatile platform 
with which to model complex systems. Our approach 
is non-proprietary and we encourage other investiga-
tors to adopt a control system approach to studying re-
lations among genes and behaviors. However, devel-
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oping equations and selecting parameters to model 
a real system is fraught with peril. To model the dy-
namics of a system one is forced to make decisions re-
garding the precise direction and magnitude of rela-
tionships among variables to a degree not required in 
static diagrams describing systems. Where practical, 
we have indicated the factors that influenced our deci-
sions about the model. Other investigators may choose 
to model specific processes or parameters differently. 
Our decisions were based on empirical data when it 
was available or on theoretical considerations with re-
spect to neurotransmitter system function. Parameter 
values were often chosen so that parameter changes 
across components would be of similar relative mag-
nitude so that artifacts of scale would not be produced. 
In the end, models such as this require validation in 
well controlled studies in biological systems. We ac-
knowledge that our work has not yet progressed to the 
stage where we can be fully confident that it fully cap-
tures the behavior of the serotonin system and we con-
tinue to work toward that end. 
A long-term goal of this research program is to use 
genotypes and other patient characteristics in a control 
system model to provide information on system func-
tion that might lead to improved diagnoses and treat-
ments. In other words, we hope that modeling efforts 
such as this might facilitate the development of person-
alized medicine (Stoltenberg 2010). 
The present findings add to the substantial litera-
ture on the effects of genetic polymorphisms on 5-HT 
function and individual differences in behavior. Specif-
ically, we presented a system of differential equations 
that appears to capture important aspects of the joint 
influence of genetic polymorphisms in the 5-HT sys-
tem on the system’s function. This work may help to 
orient investigators toward a systems approach for the 
next stage in behavior-genetic analysis that will be fo-
cused on better characterizing pathways from genes to 
behavior. 
Conclusions
Control system modeling is an approach that pro-
vides a solid platform on which to build a systems view 
of pathways from genes to behavior. Our results pro-
vide validation for this approach and suggest several 
testable hypotheses. The techniques of control system 
modeling enable investigators to explore the complex 
genetic architectures that are likely to underlie the be-
haviors and behavioral disorders of greatest interest to 
psychologists. 
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Appendix






d/dt(x1) = –(g + d) ∗ x1 + u ∗ (1 – exp(–2 ∗ x2))/ 
(1 + exp(–2 ∗ x2))
INIT x1 = 0
d/dt = g ∗ x1 – k4 ∗ x2 + r – u
 INIT x2 = 1
d/dt(c) = –c + ((k_1/k1trp) + c) ∗ y1 + v 
INIT c = 1
d/dt(y1) = (c – ((k_1 + k2trp)/k1trp + c)  ∗ y1)/e
INIT y1 = 1
d/dt(r) = –k3 ∗ r + k2trp ∗ y1
INIT r = 1
d/dt(l) = –l + ((k_1/klmaoa) + l) ∗ z1 + k4 ∗ x2
INIT l = 1
d/dt(z1) = (l – ((k_1 + k2maoa)/klmaoa + l) ∗ z1)/e
INIT z1 = 0
d/dt(p) = –k3 ∗ p + k2maoa ∗ z1
INIT p = 0
rand = RANDOM(0,1)
u = IF (SIN(TIME/PER) > 0 THEN
(IF (rand > 1 – aprob) AND ((x1 – x1th) > 0)
THEN 0 ELSE (Rmax – b ∗ x1) ∗ x2) ELSE 0
INIT Fire Rate = 0
INIT Fire = 0
FireRate(t + Dt) = FireRate + Fire
Next Fire = IF u > 0 THEN 1 ELSE 0
See Table 1
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